期刊文献+

内质网滞留型抗CyclinD1胞内抗体在HeLa细胞中的表达分析

Expression of endoplasmic reticulum-retained anti-cyclin D1 intrabody in HeLa cells
暂未订购
导出
摘要 目的构建内质网滞留型的抗CyclinD1胞内抗体并鉴定其在肿瘤细胞中的表达活性。方法利用PCR技术将细胞内质网滞留信号及E-tag检测标签引入抗CyclinD1人源单链抗体,获得抗CyclinD1胞内抗体(AD5E)基因片段,通过分子克隆技术,构建重组真核表达载体pcDNA3.1-AD5E,限制性内切酶分析及DNA测序验证其序列及读码框正确后,利用脂质体介导法转染HeLa细胞,RT-PCR和间接免疫荧光实验分析该胞内抗体在肿瘤细胞中的表达活性。结果限制性内切酶分析及DNA测序发现,正确引入细胞内质网滞留信号和E-tag检测标签序列,该胞内抗体片段为876bp。RT-PCR及免疫荧光实验结果显示,仅在转染胞内抗体基因的HeLa细胞中存在该胞内抗体的表达,并且主要分布在细胞质区域。结论我们成功构建了在肿瘤细胞中能够有效表达的内质网滞留型的抗CyclinD1胞内抗体。 Objective To construct endoplasmic reticulum-retained anti-cyclin D1 intrabody and then identify its expression in HeLa cells.Methods Using the anti-cyclin D1 scFv as template,endoplasmic reticulum-retained signal peptides (KDEL) and E-tag was introduced into anfi-cyclin D1 intrabody gene (ADSE) by PCR. Then the intrabody gene (ADSE) was subcloned into pcDNA3.1 to construct the recombinant expression vector pcDNA3.1-ADSE. Analysis of restriction endonuclease and DNA sequencing was con- ducted. The intrabody gene was transfected into human HeLa cells. RT-PCR and immunofluorescence was performed to detect the expression of this intrabedy. Results Analysis of restriction endonuclease and DNA sequencing showed that the intrabody gene and expression vector were constructed successfully. The intrabody gene was 876 bp in length. RT-PCR and immunofluorescence showed that the mRNA and proteins were only detected in the HeLa cells transfected with intrabody and the intrabody was distributed mainly in the cytoplasm. Conclusion The anti-cyclin D1 intrabody with KDEL was developed successfully. This intrabody was found to be expressed efficiently in the cytoplasm of HeLa cells.
出处 《中国实验诊断学》 2008年第7期821-824,共4页 Chinese Journal of Laboratory Diagnosis
基金 国家自然科学基金青年基金资助项目(30200256) 吉林省科技发展计划资助项目(20050410-3) 吉林吉林省杰出青年基金(200600107)
关键词 CYCLIND1 胞内抗体 表达 肿瘤 CyclinD 1 Intrabody Expression Tumor
  • 相关文献

参考文献12

  • 1Ewen M E, Lamb J. The activities of cyclin D1 that drive tumorigenesis [J] .Trends in Mol Med,2004,10:158.
  • 2Deshpande A, Sicinski P, Hinds PW. Cyclins and cdks in development and cancer: a perspective [ J ]. Oncogene ,2005,24: 2909.
  • 3Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation [J]. Nature,2001,411 : 1017.
  • 4Malumbres M, Barbaeid M. Is Cyelin D1-CDK4 kinase a bona fide cancer target [ J ]. Cancer Cell,2006,9(1): 2.
  • 5Yan KX,Liu BC,Shi XL, et al. Role of cyclinD1 and CDK4 in the carcinogenesis induced by silica [J]. Biomed Environ Sci ,2005,18(5) :286.
  • 6Arber N, Doki Y, Hart EK-H, et al. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells [J]. Cancer Res, 1997,57:1569.
  • 7Sauter ER, Nesbit M, Litwin S, et al. Antisense cyclinD1 induces apoptosis and tumor shrinkage in human squamous carcinomas [J]. Cancer Res, 1999,59 (19) :4876.
  • 8Cao T and Heng BC. Intracellular antibody (intrabodies) versus RNA interference for therapeutic application [ J ]. Ann Clin Lab Sci, 2005,35 (3):227.
  • 9Lo AS, Zhu Q, Marasco WA. Intracellular antibodies (intrabodies) and their theraputic potential [J].Handb Exp Pharmacol, 2008,181 : 343.
  • 10Moore P. Antibodies where you want them [ J ], Nature, 2003,426:729.

二级参考文献26

  • 1李春英,乔媛媛,王刚,陈宇萍,高天文,王琰.从大容量随机噬菌体抗体库筛选人源性抗酪氨酸酶相关蛋白1抗体[J].中国皮肤性病学杂志,2005,19(7):388-390. 被引量:1
  • 2Koul D, Paethasarathy R, Shen R, et al. Suppression of matrix metalloproteinase 2 gene exprssion and invasion in human glioma cells by MMAC/PTEN [J]. Oncogene, 2001, 20 (46):6669- 6678.
  • 3Rigg AS, Lemoine NR. Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant anti tumor effect in vivo [J]. Cancer Gene Therapy, 2001, 8 (11): 869- 878.
  • 4Morini M, Mottolese M, Ferrari N, et al. The α 3β 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B(MMP 9) activity [J]. Int J Cancer, 2000, 87 (3): 336- 342.
  • 5Kondraganti S, Mohanam S, Chintala SK, et al. Selective suppression of Matrix Metalloproteinase 9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion [J]. Cancer Res, 2000, 60 (24): 6851- 6855.
  • 6Fishman DA, Liu Y, Ellerbroek SM, et al. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP dependent invasion in ovarian cancer cells [J]. Cancer Res, 2001, 61 (7): 3194- 3199.
  • 7Hasegawa S, Koshikawa N, Momiyama N, et al. Matrilysin specific antisense oligonucleotide inhibits liver metastasis of human colon cells in a nude mouse model [J]. Int J Cancer, 1998, 76 (6): 812- 816.
  • 8K(a)h(a)ri VM, Saarialho kere U. Matrix metalloproteinases and their inhibitors in tumor growth and invasion [J]. Ann Med, 1999, 31 (1): 34- 45.
  • 9Hua J, Muschel RJ. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system [J]. Cancer Res, 1996, 56 (22): 5279- 5284.
  • 10Yu Q, Stamenkovic I. Cell surface localized matrix metalloproteinase 9 proteolytically activates TGF and promotes tumor invasion and angiogenesis [J]. Genes Dev, 2000, 14 (2): 163- 176.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部